List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 53 studies with search of: avastin ovarian cancer
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Efficacy and Safety and Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Doxil;   Drug: Bevacizumab (Avastin)
2 Recruiting Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients
Condition: Ovarian Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Docetaxel;   Drug: Gemcitabine;   Drug: Melphalan;   Procedure: Stem Cell Transplant
3 Completed Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: bevacizumab
4 Recruiting Pharmacokinetic Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)
Condition: Ovarian Cancer
Intervention: Drug: Doxil and Avastin
5 Active, not recruiting Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
Conditions: Advanced Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Ovarian Carcinosarcoma
Intervention: Drug: Avastin
6 Active, not recruiting TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary
Condition: Ovarian Cancer
Interventions: Drug: oxaliplatin;   Drug: docetaxel;   Drug: bevacizumab.
7 Recruiting Bevacizumab and Carboplatin for Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin
8 Recruiting Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
Condition: Ovarian Cancer
Intervention: Biological: bevacizumab
9 Completed A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed
Condition: Ovarian Cancer
Intervention: Drug: bevacizumab
10 Recruiting Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Intervention: Drug: Bevacizumab (drug), Gemcitabine (drug) & Carboplatin (drug)
11 Recruiting AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: paclitaxel;   Drug: topotecan;   Drug: liposomal doxorubicin
12 Recruiting Erlotinib and Bevacizumab in Treating Patients With Relapsed or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab;   Drug: erlotinib hydrochloride
13 Recruiting A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: paclitaxel;   Drug: carboplatin
14 Recruiting Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: paclitaxel;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: quality-of-life assessment
15 Active, not recruiting Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab;   Drug: erlotinib hydrochloride
16 Active, not recruiting Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients
Condition: Ovarian Neoplasms
Intervention: Drug: Avastin
17 Completed Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab;   Drug: cyclophosphamide
18 Active, not recruiting Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Avastin
19 Recruiting Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor
Conditions: Breast Cancer;   Ovarian Cancer
Interventions: Drug: Bevacizumab;   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Fludarabine;   Drug: Melphalan
20 Terminated Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer;   Stage 3 Cancer;   Stage 4 Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Paclitaxel

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services